In fact, it was described that miR-21 is involved in positive hormonal breast carcinoma especially in those expressing HER2 that upregulate miR-21 and, therefore, it is involved in positive hormonal breast cancer subtypes since it appeared to interact with the α ER pathway [33], [34], [35]. Here, ERBB2 is linked to breast cancer.